Aditxt (NASDAQ:ADTX) Major Shareholder Financial Lp Hrt Purchases 4,252,767 Shares

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt acquired 4,252,767 shares of the stock in a transaction dated Friday, June 12th. The shares were bought at an average cost of $0.02 per share, for a total transaction of $85,055.34. Following the completion of the transaction, the insider owned 2,459,308 shares in the company, valued at approximately $49,186.16. This represents a -237.13% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total value of $44,127.72.
• On Thursday, June 4th, Financial Lp Hrt acquired 843,622 shares of Aditxt stock. The shares were bought at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total value of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total value of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt acquired 2,700 shares of Aditxt stock. The shares were bought at an average cost of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The shares were sold at an average price of $8.10, for a total value of $3,588.30.

Aditxt Price Performance

Shares of ADTX stock traded up $0.00 during trading hours on Tuesday, reaching $0.01. 471,683,418 shares of the company traded hands, compared to its average volume of 36,197,617. Aditxt, Inc. has a 12-month low of $0.01 and a 12-month high of $53,451.08. The company has a market cap of $10,988.00, a P/E ratio of 0.00 and a beta of 0.84. The firm has a 50-day moving average price of $5.02 and a 200 day moving average price of $140.79.

Aditxt (NASDAQ:ADTX) last issued its earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share (EPS) for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Wall Street Zen raised Aditxt to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Aditxt presently has an average rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.